Combining semi‑quantitative rating and automated brain volumetry in MRI evaluation of patients with probable behavioural variant of frontotemporal dementia: an added value for clinical practise?
DIAGNOSTIC NEURORADIOLOGY, 2023
Sonia Francesca Calloni, Paolo Quintiliano Vezzulli, Antonella Castellano, Riccardo Leone, Silvia Basaia, Almar von Loon, Edoardo Gioele Spinelli, Giuseppe Magnani, Francesca Caso, Federica Agosta, Massimo Filippi & Andrea Falini
- The study set out to evaluate whether combining semiquantitative and quantitative assessment of brain atrophy would add value in clinically diagnosing the behavioural-variant of frontotemporal dementia (bvFTD). A general trend of higher accuracy in diagnosing bvFTD was observed, when using the semiquantitative assessment alone, or combining both.
- Quantib® ND was used as one of the methods to perform automated quantitative atrophy assessment.
Learn more
Disclaimers:
DeepHealth Prostate is manufactured as Quantib Prostate by Quantib BV for DeepHealth Inc.,
DeepHealth Lung is manufactured as Veye Lung Nodules by Aidence BV for DeepHealth Inc.,
DeepHeath Lung Tracker is manufactured as Veye Clinic by Aidence BV for DeepHealth Inc. and
DeepHealth Brain is manufactured as Quantib ND by Quantib BV for DeepHealth Inc.
Not all products and functionalities are commercially available in all countries. For clearance and commercial
availability in your geography of functionalities listed and compatibility with other systems, please
contact us
